Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?

Inhaled corticosteroids (ICSs) are a mainstay of COPD treatment for patients with a history of exacerbations. Initial studies evaluating their use as monotherapy failed to show an effect on rate of pulmonary function decline in COPD, despite improvements in symptoms and reductions in exacerbations....

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P, Strange, Charlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118265/
https://www.ncbi.nlm.nih.gov/pubmed/30214177
http://dx.doi.org/10.2147/COPD.S172240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118265/
https://www.ncbi.nlm.nih.gov/pubmed/30214177
http://dx.doi.org/10.2147/COPD.S172240

Ejemplares similares